Dr. Hisham Khalil - Almoosa Health group

Degree

• Bachelor of Medicine and Surgery

• Master’s Degree in Cardiovascular Medicine – Cairo University – November 1995

• MD Degree in Cardiovascular Medicine – Cairo University – April 2004

• Diploma of Cardiovascular and Peripheral Intervention – Chang Gung Memorial Hospital, Taiwan – April 2009

• Fellow of the American College of Cardiology (FACC) – USA – February 2013

• Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI) – USA – October 2013

Areas Of Expertise

Coronary and Ischemic Heart Disease

• Stable angina, unstable angina, NSTEMI, and STEMI

• Complex coronary artery disease involving left main, bifurcation, multivessel, and chronic total occlusions (CTO)

• In•stent restenosis and post•PCI optimization using IVUS and OCT

• Ischemia evaluation using stress testing, cardiac CT, or invasive physiology (FFR, iFR)

Structural and Valvular Heart Diseases

• Severe aortic stenosis (Transcatheter Aortic Valve Implantation – TAVI)

Pulmonary and Peripheral Vascular Diseases

• Percutaneous intervention for acute pulmonary embolism (PE)

• Deep vein thrombosis (DVT) and venous thromboembolism management

• Peripheral artery disease assessment and endovascular treatment

Heart Failure and Cardiomyopathies

• Ischemic and non•ischemic cardiomyopathy

• Advanced heart failure management and evaluation for device therapy (ICD, CRT)

• Cardiac resynchronization therapy optimization and follow•up

• Pulmonary hypertension and right heart failure management

Arrhythmias and Conduction Disorders

• Atrial fibrillation, atrial flutter, and supraventricular tachycardia (SVT)

• Ventricular tachycardia, frequent PVCs, and palpitations evaluation

• Syncope evaluation and cardiac rhythm monitoring

• Post•pacemaker and defibrillator follow•up

Hypertension, Dyslipidemia, and Preventive Cardiology

• Resistant hypertension, secondary hypertension evaluation

• Dyslipidemia management (familial, statin•intolerant, PCSK9 therapy)

• Diabetes•related cardiac risk management

• Lifestyle and pharmacologic secondary prevention after myocardial infarction or bypass surgery

Non•Invasive Cardiac Imaging

• Transthoracic, transesophageal, and stress echocardiography

• Cardiac CT angiography for coronary and structural heart evaluation

• Nuclear cardiology and myocardial perfusion imaging

• Functional and structural cardiac assessment in preoperative and post•procedural patients

Cardiac Rehabilitation and Long•Term Follow•Up

• Structured cardiac rehabilitation for post•MI, PCI, and cardiac surgery patients

• Comprehensive follow•up after structural heart and coronary interventions

• Optimization of medical therapy and risk factor control

Nationality

EGYPTIAN

Languages

Arabic

English